Rugo, H. S., Pritchard, K. I., Gnant, M., Noguchi, S., Piccart, M., Hortobagyi, G., . . . Center, U. H. D. F. C. C. (2018). Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: Insights from BOLERO-2.
استشهاد بنمط شيكاغوRugo, H. S., et al. Incidence and Time Course of Everolimus-related Adverse Events in Postmenopausal Women With Hormone Receptor-positive Advanced Breast Cancer: Insights From BOLERO-2. 2018.
MLA استشهادRugo, H. S., et al. Incidence and Time Course of Everolimus-related Adverse Events in Postmenopausal Women With Hormone Receptor-positive Advanced Breast Cancer: Insights From BOLERO-2. 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.